Table 2.

Clinical features, Laboratory tests, and CT scan of COVID-19 in children with positive and negative results in stool specimens.

		Median (IQR)
	Normal range	Total (N = 10)	Positive (7,70%)	Negative (3,30%)	p
Age, median, y		5.08	4.69	6.00	0.68
Gender		M (3,30%)	M (3,42.9%)	M (0,0%)	0.18
		F (7,70%)	F (4,57.1%)	F (3,100%)
Clinical type					0.49
Mild		1,10%	1,14.3%	0,0%
Conventional		9,90%	6,85.7%	3,100%
symptomatic		5,50%	3,42.9%	2,66.7%	0.49
asymptomatic		5,50%	4,57.1%	1,33.3%
Time, days		3.75 ± 5.91	2.21 ± 1.78	7.33 ± 10.97	0.50
Hospital stays		19.80 ± 6.70	17.71 ± 4.68	24.67 ± 9.24	0.14
Signs and symptoms
Fever		4,40%	3,42.9%	1,33.3%	0.78
Dry cough		2,20%	0,0%	2,66.7%	0.02
Phlegm		1,10%	0.0%	1,33.3%	0.11
WBC × 109/L	4−10	6.35 ± 2.77	6.68 ± 2.77	5.60 ± 3.23	0.60
N × 109/L	2−7	1.85 ± 0.60	1.89 ± 0.60	1.77 ± 0.74	0.79
L × 109/L	0.8−4	4.03 ± 2.26	4.34 ± 2.27	3.30 ± 2.52	0.54
M × 109/L	0.12−0.8	0.35 ± 0.12	0.31 ± 0.12	0.43 ± 0.06	0.15
HBG	110−150	125.90 ± 7.85	125.57 ± 8.68	126.67 ± 7.09	0.85
PLT × 109/L	100−300	244.2 ± 89.69	237.0 ± 106.04	261.00 ± 43.09	0.72
ALT	0−40	24.80 ± 34.32	29.29 ± 41.09	14.33 ± 1.15	0.56
AST	0−40	31.30 ± 7.09	32.29 ± 7.57	29.00 ± 6.58	0.53
CRP	0.068−8.2	1.38 ± 3.34	1.86 ± 3.98	0.25 ± 0.11	0.52
PCT	0−0.05	0.05 ± 0.02	0.04 ± 0.02	0.05 ± 0.02	0.57
LDH	109−245	307.9 ± 92.47	302.14 ± 65.99	321.33 ± 158.21	0.86
CK	26−140	99.80 ± 45.54	101.97 ± 55.35	94.73 ± 9.21	0.75
Myo	10−46	11.67 ± 3.99	12.38 ± 4.42	10.00 ± 2.65	0.42
Ctn	0−0.01	0.01 ± 0.00	0.01 ± 0.00	0.010.00
BUN	2.9−8.2	4.25 ± 1.31	4.53 ± 1.42	3.60 ± 0.87	0.33
Cr	50.4−98.1	44.61 ± 5.83	45.47 ± 6.94	42.60 ± 0.36	0.51
PT	8.8−13.8	12.01 ± 0.50	12.02 ± 0.36	12.00 ± 0.85	0.96
D-dimer	0−0.5	0.34 ± 0.20	0..40 ± 0.20	0.21 ± 0.12	0.17
IL-6	0−7	2.50 ± 2.49	2.93 ± 2.94	1.50 ± 0.00	0.44
Pneumonia		9,90%	6,85.7%	3,100%	0.49
CT (bilateral)		6,66.7%	5,83.3%	1,33.3%	0.13
CT (unilateral)		3,33.3%	1,16.7%	2,66.7%

Note: Time; from onset to diagnosis.